Dr. Zheng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-456-2382Fax+1 214-456-6133
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2017 - 2020- Children's Hospital of PhiladelphiaResidency, Pediatrics, 2014 - 2017
Weill Cornell MedicineClass of 2014
Certifications & Licensure
TX State Medical License 2021 - 2025
PA State Medical License 2014 - 2021- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 62 citationsRetention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19.Mukta Asnani, Katharina E. Hayer, Ammar S. Naqvi, Sisi Zheng, Scarlett Y. Yang
Leukemia. 2020-04-01 - 13 citationsEscape From ALL-CARTaz: Leukemia Immunoediting in the Age of Chimeric Antigen Receptors.Sisi Zheng, Mukta Asnani, Andrei Thomas-Tikhonenko
Cancer Journal. 2019-05-01 - 11 citationsAlternative splicing of its 5'-UTR limits CD20 mRNA translation and enables resistance to CD20-directed immunotherapies.Zhiwei Ang, Luca Paruzzo, Katharina E Hayer, Carolin Schmidt, Manuel Torres Diz
Blood. 2023-11-16
Press Mentions
- Aberrant Splicing of CD22 in Acute Lymphoblastic Leukemia Underlies Resistance to ImmunotherapyJanuary 4th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
